Literature DB >> 2679553

Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma.

Y T Xuan1, A R Whorton, E Shearer-Poor, J Boyd, W D Watkins.   

Abstract

We have developed a sensitive and selective radioimmunoassay for porcine/human endothelin (ET1). The assay has a detection limit of 0.62 pg/tube and exhibits no cross-reactivity to atrial natriuretic peptide, arginine vasopressin, or angiotensin II. Procedures were developed for extraction of endothelin from human plasma samples and samples of buffer from endothelial cell incubations using C18 Sep-Pak extraction cartridges. The mean recovery following extraction was approximately 80%. Both bovine and porcine aortic endothelial cells were found to produce immunoreactive endothelin (IR-ET) with porcine cells producing 4.7 +/- 1.1 ng of IR-ET/mg cell protein after 6 hours. Human plasma samples were extracted, assayed and found to contain a mean concentration of 2.0 +/- 0.4 pg/ml of IR-ET.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679553     DOI: 10.1016/0006-291x(89)91721-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40.

Authors:  A Urakami; S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; T Shimamura; E Totsuka; V Subbotin; R Lee; T E Starzl
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

2.  Activation of muscarinic K+ current in guinea-pig atrial myocytes by a serum factor.

Authors:  K Banach; J Hüser; P Lipp; M C Wellner; L Pott
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

3.  Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.

Authors:  Amee Shah; Angela M Feraco; Cynthia Harmon; Theresa Tacy; Jeffrey R Fineman; Harold S Bernstein
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

4.  Alterations in circulating vasoactive substances in the critically ill--a comparison between survivors and non-survivors.

Authors:  J Boldt; T Menges; D Kuhn; C Diridis; G Hempelmann
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.